2004
DOI: 10.1016/s0360-3016(03)01570-0
|View full text |Cite
|
Sign up to set email alerts
|

Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

12
163
2
4

Year Published

2007
2007
2019
2019

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 267 publications
(181 citation statements)
references
References 17 publications
12
163
2
4
Order By: Relevance
“…It is not clear whether the presence of HY constitutes a prognostic factor because both increased mortality (12) and lack of association with mortality have been reported (13,14,15,16). Our retrospective analyses of the thus far largest published cohort of long-term survivors of childhood-onset CP and CRP show that HY at diagnosis was not associated with reduced survival rates and impaired FC during long-term follow-up, supporting previous reports (13,14,15,16).…”
Section: European Journal Of Endocrinologysupporting
confidence: 78%
See 4 more Smart Citations
“…It is not clear whether the presence of HY constitutes a prognostic factor because both increased mortality (12) and lack of association with mortality have been reported (13,14,15,16). Our retrospective analyses of the thus far largest published cohort of long-term survivors of childhood-onset CP and CRP show that HY at diagnosis was not associated with reduced survival rates and impaired FC during long-term follow-up, supporting previous reports (13,14,15,16).…”
Section: European Journal Of Endocrinologysupporting
confidence: 78%
“…The OS rates (which reflect effect of multiple treatments) described in an exclusively pediatric series ranged from 83 to 96% at 5 years (14, 15, 17, 30, 31, 32, 33) and 65 to 100% at 10 years (15, 26, 30, 31, 32, 34, 35, 36, 37, 38, 39, 40, 41), averaging 62% at 20 years (42). In adults or a broad age-range population (adults and children) series, the OS rates ranged from 54 to 96% at 5 years (13,16,25,29,32,43,44,45,46), 40 to 93% at 10 years (13,16,25,28,29,32,43,44,45,46), and 66 to 85% at 20 years (29,45,46). The lower limits of survival rates usually reflected data from earlier series that occurred before modern advances in microsurgery, neuroimaging, and radiotherapy.…”
Section: European Journal Of Endocrinologymentioning
confidence: 99%
See 3 more Smart Citations